Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$49.8K Buy
14,900
+400
+3% +$1.33K ﹤0.01% 1125
2025
Q4
$45.5K Buy
+14,500
New +$57.7K ﹤0.01% 1241
2024
Q1
Sell
-1,344
Closed -$22.3K 1291
2023
Q4
$22.3K Buy
+1,344
New +$22.3K ﹤0.01% 1092
2023
Q2
Sell
-540
Closed -$16.1K 1099
2023
Q1
$16.1K Buy
+540
New +$22.8K ﹤0.01% 1051
2022
Q1
Sell
-692
Closed -$44K 1767
2021
Q4
$44K Buy
+692
New +$54.6K ﹤0.01% 1787
2018
Q2
Sell
-57
Closed -$5K 1627
2018
Q1
$5K Sell
57
-28
-33% -$2.49K ﹤0.01% 1415
2017
Q4
$5K Sell
85
-128
-60% -$9.77K ﹤0.01% 1261
2017
Q3
$18K Buy
213
+105
+97% +$8.51K ﹤0.01% 1335
2017
Q2
$8K Sell
108
-167
-61% -$11.7K ﹤0.01% 1420
2017
Q1
$20K Buy
+275
New +$21.8K ﹤0.01% 1277
2016
Q4
Sell
-61
Closed -$9K 1514
2016
Q3
$9K Buy
61
+5
+9% +$573 ﹤0.01% 1437
2016
Q2
$4K Buy
+56
New +$4.37K ﹤0.01% 1473

Other funds holding AGEN

Prelude Capital Management's AGEN Position: Q1 2026 in Review

Prelude Capital Management increased its Agenus (AGEN) stake by 2.8% in Q1 2026, buying an estimated $1.33K and bringing the position to 14,900 shares worth $49.8K. The position accounts for ﹤0.01% of the portfolio, ranked #1125.

Prelude Capital Management first reported a position in AGEN in Q2 2016 and has held it in 12 quarters since. 88 funds tracked by Wall St. Rank hold AGEN as of Q1 2026.

  • Prelude Capital Management held 14,900 shares of Agenus worth $49.8K as of Q1 2026.
  • Prelude Capital Management bought 400 Agenus shares in Q1 2026, an estimated $1.33K.
  • Agenus made up ﹤0.01% of Prelude Capital Management's portfolio in Q1 2026, its #1125 holding.
  • Prelude Capital Management first reported a position in Agenus in Q2 2016 and has held it in 12 quarters since.
  • 88 funds tracked by Wall St. Rank held Agenus as of Q1 2026.

Based on Prelude Capital Management's 13F filing for Q1 2026, filed 15 May 2026.